| Müügiloata ravim |
1784954
|
[177Lu]Lu-PSMA-I&T |
V10XX85 |
luteetsium(177Lu)-PSMA-I&T |
süstelahus |
1TK |
MAP Medical Technologies Oy |
R |
|
|
|
|
|
|
|
|
| Müügiloata ravim |
1524721
|
177LU-DOTA-TATE ([177LU]DOTA-(TYR3)-OCTREOTATE |
V09IX81 |
luteetsium(177Lu)-DOTA-Tyr3-oktreotaat |
süstelahus |
1TK |
MAP Medical Technologies Oy |
R |
|
|
|
|
|
|
|
|
| Müügiloaga pakend |
1725791
|
ENDOLUCINBETA |
V10XX84 |
luteetsium(177Lu)kloriid |
radiofarmatseutilise prekursori lahus |
40GBq 1ml 10ml 1TK |
ITG Isotope Technologies Garching GmbH |
R |
|
|
|
|
 |
|
|
Jah |
| Müügiloaga pakend |
1725780
|
ENDOLUCINBETA |
V10XX84 |
luteetsium(177Lu)kloriid |
radiofarmatseutilise prekursori lahus |
40GBq 1ml 2ml 1TK |
ITG Isotope Technologies Garching GmbH |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1749180
|
IODOPOL |
V10XA01 |
naatriumjodiid (131I) |
kõvakapsel |
1TK |
Narodowe Centrum Badan Jadrowych |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloata ravim |
1603280
|
LU177 TRICHLORIDE |
V10XX82 |
luteetsium(177Lu)trikloriid |
infusioonilahus |
1TK |
Idb Holland B.V. |
R |
|
|
|
|
|
|
|
|
| Müügiloaga pakend |
1691737
|
LUMARK |
V10XX84 |
luteetsium(177Lu)kloriid |
radiofarmatseutilise prekursori lahus |
1TK |
Idb Holland B.V. |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloaga pakend |
1617184
|
LUTATHERA |
V10XX04 |
luteetsium(177Lu)oksodotreotiid |
infusioonilahus |
370MBq 1ml 20.5ml 1TK |
Advanced Accelerator Applications |
R |
|
|
|
18.05.2022 |
|
|
Jah |
Jah |
| Müügiloata ravim |
1761241
|
META-IODOBENZYLGUANIDINE (131 I) FOR THERAPEUTIC USE 185-740 MBq/ml |
V10XA02 |
jobenguaan (131I) |
süste-/infusioonilahus |
1TK |
GE Healthcare Buchler GmbH & Co. KG |
R |
|
|
|
|
|
|
|
|
| Müügiloaga pakend |
1197301
|
QUADRAMET |
V10BX02 |
samaarium(153Sm)leksidronaam |
süstelahus |
1,3GBq 1ml 1TK |
Cis Bio International |
R |
|
|
|
06.08.2020 |
|
|
|
Jah |
| Müügiloata ravim |
1798588
|
RHENIUM (186RE) SULPHIDE CIS BIO INTERNATIONAL |
V10AX05 |
reeniumsulfiid(186Re)kolloid |
süstesuspensioon |
1TK |
Cis Bio International |
R |
|
|
|
|
|
|
|
|
| Müügiloata ravim |
1326754
|
SODIUM IODIDE (I-131) CAPSULES FOR THERAPY |
V10XA01 |
naatriumjodiid (131I) |
pehmekapsel |
1TK |
MAP Medical Technologies Oy |
R |
|
|
|
|
|
|
|
|
| Müügiloata ravim |
1811236
|
ZEVALIN |
V10XX02 |
ibritumomabtiuksetaan |
radiofarmatseutiline komplekt |
1,6mg 1ml 10ml 1TK |
Ceft Biopharma s.r.o. |
R |
|
|
|
|
|
|
|
|
| Müügiloaga pakend |
1208203
|
ZEVALIN |
V10XX02 |
ibritumomabtiuksetaan |
radiofarmatseutiline komplekt |
1,6mg 1ml 2ml 1TK |
Ceft Biopharma s.r.o. |
R |
|
|
|
30.05.2011 |
|
|
|
Jah |
| Müügiloaga pakend |
1080133
|
THERACAP |
V10XA01 |
naatriumjodiid (131I) |
kõvakapsel |
1TK |
GE Healthcare Buchler GmbH & Co. KG |
R |
|
|
|
23.05.2022 |
|
|
|
Jah |
| Müügiloaga pakend |
1632293
|
XOFIGO |
V10XX03 |
raadium(Ra223)dikloriid |
süstelahus |
1100kBq 1ml 6ml 1TK |
Bayer AG |
R |
|
|
|
28.04.2022 |
|
|
|
Jah |
| Müügiloata ravim |
1208214
|
YTRACIS |
V10AA80 |
ütrium(90Y)kloriid |
radiofarmatseutilise prekursori lahus |
1,85GBq 1ml 1TK |
Cis Bio International |
R |
|
|
|
16.11.2012 |
|
|
|
|
| Müügiloaga pakend |
1225707
|
YTTRIGA |
V10AA80 |
ütrium(90Y)kloriid |
radiofarmatseutilise prekursori lahus |
1TK |
Eckert & Ziegler Radiopharma GmbH |
R |
|
|
|
|
|
|
|
Jah |
| Müügiloata ravim |
1236136
|
YTTRIUM (90-Y) COLLOID SUSPENSION YMM-1 |
V10AA01 |
ütrium(90Y)tsitraat, kolloidne |
süstesuspensioon |
370MBq 1ml 1ml 1TK |
IBA Molecular |
R |
|
|
|
|
|
|
|
|